Skip to main content
Top
Published in: Familial Cancer 4/2015

01-12-2015 | Original Article

A functional HOTAIR rs920778 polymorphism does not contributes to gastric cancer in a Turkish population: a case–control study

Authors: Süleyman Bayram, Yakup Ülger, Ahmet Taner Sümbül, Berrin Yalınbaş Kaya, Ahmet Rencüzoğulları, Ahmet Genç, Yusuf Sevgiler, Onur Bozkurt, Eyyüp Rencüzoğulları

Published in: Familial Cancer | Issue 4/2015

Login to get access

Abstract

An aberrant up-regulation of HOX transcript antisense intergenic RNA (HOTAIR), a long non-coding RNA (lncRNA), is associated with human cancers including gastric cancer (GC) and worse clinicopathological features. A naturally occurring functional single nucleotide polymorphism (SNP) rs920,778 (C→T) in the intronic enhancer of HOTAIR gene has been demonstrated to affect HOTAIR expression and cancer susceptibility. To investigate the association of the HOTAIR rs920778 polymorphism on the risk of GC susceptibility in Turkish population, a hospital-based case–control study was carried out consisting of 104 GC and 209 healthy control subjects matched on age and gender. The genotype frequency of HOTAIR rs920778 polymorphism was determined by using TaqMan Real-Time Polymerase Chain Reaction. No statistically significant differences were found in the allele or genotype distributions of the HOTAIR rs920778 polymorphism among GC and healthy control subjects (P > 0.05). Our results demonstrate that the HOTAIR rs920778 polymorphism has not been in any major role in genetic susceptibility to gastric carcinogenesis, at least in the population studied here. Independent studies are needed to validate our findings in a larger series, as well as in patients of different ethnic origins.
Literature
1.
go back to reference Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2014) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. doi:10.1002/ijc.29210 PubMed Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2014) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. doi:10.​1002/​ijc.​29210 PubMed
2.
go back to reference Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray, F. GLOBOCAN 2012 v1.0, Cancer incidence and mortality worldwide: IARC Cancer Base No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. Available from: http://globocan.iarc.fr. Accessed on 22 Jan 2015 Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray, F. GLOBOCAN 2012 v1.0, Cancer incidence and mortality worldwide: IARC Cancer Base No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. Available from: http://​globocan.​iarc.​fr. Accessed on 22 Jan 2015
11.
12.
14.
go back to reference Gupta RA, Shah N, Wang KC, Kim J, Horlings HM, Wong DJ, Tsai MC, Hung T, Argani P, Rinn JL, Wang Y, Brzoska P, Kong B, Li R, West RB, van de Vijver MJ, Sukumar S, Chang HY (2010) Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 464:1071–1076. doi:10.1038/nature08975 PubMedCentralCrossRefPubMed Gupta RA, Shah N, Wang KC, Kim J, Horlings HM, Wong DJ, Tsai MC, Hung T, Argani P, Rinn JL, Wang Y, Brzoska P, Kong B, Li R, West RB, van de Vijver MJ, Sukumar S, Chang HY (2010) Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 464:1071–1076. doi:10.​1038/​nature08975 PubMedCentralCrossRefPubMed
15.
go back to reference Zhang X, Zhou L, Fu G, Sun F, Shi J, Wei J, Lu C, Zhou C, Yuan Q, Yang M (2014) The identification of an ESCC susceptibility SNP rs920778 that regulates the expression of lncRNA HOTAIR via a novel intronic enhancer. Carcinogenesis 35:2062–2067. doi:10.1093/carcin/bgu103 CrossRefPubMed Zhang X, Zhou L, Fu G, Sun F, Shi J, Wei J, Lu C, Zhou C, Yuan Q, Yang M (2014) The identification of an ESCC susceptibility SNP rs920778 that regulates the expression of lncRNA HOTAIR via a novel intronic enhancer. Carcinogenesis 35:2062–2067. doi:10.​1093/​carcin/​bgu103 CrossRefPubMed
16.
go back to reference Bayram S, Sümbül AT, Batmacı CY, Genç A (2015) Effect of HOTAIR rs920778 polymorphism on breast cancer susceptibility and clinicopathologic features in a Turkish population. Tumour Biol. doi:10.1007/s13277-014-3028-0 Bayram S, Sümbül AT, Batmacı CY, Genç A (2015) Effect of HOTAIR rs920778 polymorphism on breast cancer susceptibility and clinicopathologic features in a Turkish population. Tumour Biol. doi:10.​1007/​s13277-014-3028-0
17.
go back to reference Pan W, Liu L, Wei J, Ge Y, Zhang J, Chen H, Zhou L, Yuan Q, Zhou C, Yang M (2015) A functional lncRNA HOTAIR genetic variant contributes to gastric cancer susceptibility. Mol Carcinog. doi:10.1002/mc.22261 Pan W, Liu L, Wei J, Ge Y, Zhang J, Chen H, Zhou L, Yuan Q, Zhou C, Yang M (2015) A functional lncRNA HOTAIR genetic variant contributes to gastric cancer susceptibility. Mol Carcinog. doi:10.​1002/​mc.​22261
21.
go back to reference Guo W, Dong Z, Bai Y, Guo Y, Shen S, Kuang G, Xu J (2014) Associations between polymorphisms of HOTAIR and risk of gastric cardia adenocarcinoma in a population of north China. Tumour Biol. doi:10.1007/s13277-014-2912-y Guo W, Dong Z, Bai Y, Guo Y, Shen S, Kuang G, Xu J (2014) Associations between polymorphisms of HOTAIR and risk of gastric cardia adenocarcinoma in a population of north China. Tumour Biol. doi:10.​1007/​s13277-014-2912-y
Metadata
Title
A functional HOTAIR rs920778 polymorphism does not contributes to gastric cancer in a Turkish population: a case–control study
Authors
Süleyman Bayram
Yakup Ülger
Ahmet Taner Sümbül
Berrin Yalınbaş Kaya
Ahmet Rencüzoğulları
Ahmet Genç
Yusuf Sevgiler
Onur Bozkurt
Eyyüp Rencüzoğulları
Publication date
01-12-2015
Publisher
Springer Netherlands
Published in
Familial Cancer / Issue 4/2015
Print ISSN: 1389-9600
Electronic ISSN: 1573-7292
DOI
https://doi.org/10.1007/s10689-015-9813-0

Other articles of this Issue 4/2015

Familial Cancer 4/2015 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine